Previous studies have shown that EGFR polymorphisms are associated with patient prognosis in a variety of cancers such as head and neck cancer [25], lung cancer [26], colorectal carcinoma [27], breast cancer [28], bladder cancer [29] and esophageal cancer [30]. The gene discussed is EGFR; the disease is breast carcinoma.